Trials / Enrolling By Invitation
Enrolling By InvitationNCT06709794
Evaluating the Effect of Automatic Plan Assignment and Enhanced Outreach of Marketplace Take-up
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30,000 (estimated)
- Sponsor
- Covered California · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Facilitated enrollment offers a potential solution to some administrative burdens and choice frictions that may produce incomplete take-up of marketplace coverage. Because Covered California, California's ACA individual marketplace, and Medi-Cal, California's Medicaid program, share an eligibility system, Covered California has the ability to identify individuals who are eligible for marketplace coverage upon losing Medicaid eligibility. This evaluation will compare the effectiveness of facilitated enrollment strategies, including personalized plan pre-selection and personalized quotes of net premiums, to other enhanced, but general outreach tactics, on marketplace take-up among individuals losing Medi-Cal coverage.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Informational flyer | In addition to a standard eligibility notice informing participants of their eligibility for marketplace coverage, they receive an informational flyer describing what Covered California is, the availability of financial assistance, and information on benefit design and private insurance terminology, such as deductibles and copays |
| BEHAVIORAL | Modified eligibility notice with plan information | a modified eligibility notice that includes information on the pre-selected lowest-cost silver health insurance plan with a personalized quote for their net premium amount in addition to the informational flyer and instead of a standard eligibility notice |
Timeline
- Start date
- 2024-03-25
- Primary completion
- 2026-12-31
- Completion
- 2028-12-31
- First posted
- 2024-11-29
- Last updated
- 2024-11-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06709794. Inclusion in this directory is not an endorsement.